Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults
Authors:
- C J SkillicornCSC J Skillicorn
- S J HowellSHS J Howell
- C LissettCLC Lissett
- A RahimARA Rahim
- S M ShaletSSS M Shalet
- 1 June 1999
- journal article
- clinical trial
- Published by Wiley in Clinical Endocrinology
- Vol. 50 (6) , 749-757
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective StudyScience, 1998
- The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient AdultsThe Journal of Clinical Endocrinology & Metabolism, 1998
- Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial.The Journal of Clinical Endocrinology & Metabolism, 1995
- Characteristics of adults who wish to enter a trial of growth hormone replacementClinical Endocrinology, 1995
- Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly womenThe Journal of Clinical Endocrinology & Metabolism, 1994
- Reduced bone mineral density in patients with adult onset growth hormone deficiencyThe Journal of Clinical Endocrinology & Metabolism, 1994
- Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiencyMetabolism, 1993
- Treatment of adults with growth hormone (GH) deficiency with recombinant human GHThe Journal of Clinical Endocrinology & Metabolism, 1993
- The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body compositionClinical Endocrinology, 1992